ArticleFrontiers in oncology2021

CT-Based Peritumoral and Intratumoral Radiomics as Pretreatment Predictors of Atypical Responses to Immune Checkpoint Inhibitor Across Tumor Types: A Preliminary Multicenter Study.

Shuai He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.